advertisement

WGA Rescources

11.16 Vehicles, delivery systems, pharmacokinetics, formulation (14)

Showing records 1 to 14

Display all abstracts in classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation

Search within classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation
17562 Neuroprotection of retinal ganglion cells in DBA/2J mice with GDNF-loaded biodegradable microspheres
Ward MS; Khoobehi A; Lavik EB; Langer R; Young MJ
Journal of Pharmaceutical Sciences 2007; 96: 558-568
18103 Phosphate concentrations in antiglaucoma medication
Bernauer W; Thiel MA; Rentsch KM
Klinische Monatsblätter für Augenheilkunde 2007; 224: 249-251
17609 Ocular disposition, pharmacokinetics, efficacy and safety of nanoparticle-formulated ophthalmic drugs
Bu H-Z; Gukasyan HJ; Goulet L; Lou X-J; Xiang C; Koudriakova T
Current drug metabolism 2007; 8: 91-107
18087 Levels of bimatoprost acid in the aqueous humour after bimatoprost treatment of patients with cataract
Cantor LB; Hoop J; WuDunn D; Yung CW; Catoira Y; Valluri S; Cortes A; Acheampong A; Woodward DF; Wheeler LA
British Journal of Ophthalmology 2007; 91: 629-632
17606 Liposome-encapsulated mitomycin C for the reduction of corneal healing rate and ocular toxicity
Chetoni P; Burgalassi S; Monti D; Najarro M; Boldrini E
Journal of Drug Delivery Science and Technology 2007; 17: 43-48
17518 Accuracy and performance of a commercially available dosing aid
Cronin TH; Kahook MY; Lathrop KL; Noecker RJ
British Journal of Ophthalmology 2007; 91: 497-499
18037 The TRAVATAN Dosing Aid accurately records when drops are taken
Friedman DS; Jampel HD; Congdon NG; Miller R; Quigley HA
American Journal of Ophthalmology 2007; 143: 699-701
18019 Ocular symptoms and signs with preserved and preservative-free glaucoma medications
Jaenen N; Baudouin C; Pouliquen P; Manni G; Figueiredo A; Zeyen T
European Journal of Ophthalmology 2007; 17: 341-349
17534 Developments in dosing aids and adherence devices for glaucoma therapy: Current and future perspectives
Kahook MY
Expert Review of Medical Devices 2007; 4: 261-266
17607 Development of a vesicular system for effective ocular delivery of acetazolamide A comprehensive approach and successful venture
Kaur IP; Mitra AK; Aggarwal D
Journal of Drug Delivery Science and Technology 2007; 17: 33-41
17605 Ocular transport model for ophthalmic delivery of timolol through p-HEMA contact lenses
Li CC; Chauhan A
Journal of Drug Delivery Science and Technology 2007; 17: 69-79
17610 Transscleral diffusion of ethacrynic acid and sodium fluorescein
Lin C-W; Wang Y; Challa P; Epstein DL; Yuan F
Molecular Vision 2007; 13: 243-251
18073 Ocular drug delivery: molecules, cells, and genes
Liu X; Brandt CR; Rasmussen CA; Kaufman PL
Canadian Journal of Ophthalmology 2007; 42: 447-454
18015 Penetration of betaxolol HCL ionic suspension 0.25% and betaxolol HCL solution 0.50% into the aqueous humor
Sagdic Yalvac I; Basci NE; Dulger B; Duman S
European Journal of Ophthalmology 2007; 17: 368-371

Issue 9-2

Change Issue


advertisement

Topcon